Первая пятница декабря
Конгресс 2014
Новости офтальмологии
Скоро она будет размещена в сети, и конечно же в бюллетене Новости глаукомы (№4, 2019, осень)
Immunocore Limited yesterday presented new biomarker research data for effects of Tebentafusp (IMCgp100) on patients with advanced uveal and cutaneous melanoma. Monotherapy treatment with the first-in-class ImmTAC® molecule tebentafusp was found to induce an immunologically potent response in patients. These findings, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, provide additional insight into the mechanism of action of tebentafusp in patients with advanced melanoma and demonstrates the potential association with clinical outcomes.
Purpose: The aim of this study was to evaluate the influence of four different types of speculums on aberrometry reading (OPD SCAN III [OPD]) and on intraoperative aberrometry reading (optiwave response analyzer, ORA).
Скоро подписчики его получат! А авторов приглашаем к сотрудничеству!
Dr Kenneth Fong (Sunway Medical Center – Malaysia) explains the interest of 577nm SubLiminal laser in the treatment of DME (видео)
Приказ Министерства здравоохранения РФ от 28 февраля 2019 г. № 103н "Об утверждении порядка и сроков разработки клинических рекомендаций, их пересмотра, типовой формы клинических рекомендаций и требований к их структуре, составу и научной обоснованности включаемой в клинические рекомендации информации”.
Вебинары, 23 мая, приблизительно в 17-00 по мск времени. Следим?
Can GATT be an Effective Surgical Option for POAG in Developing Countries?
Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser has been announced as the approved delivery device for Bausch+Lomb’s Levofree Multidose in France. This marks the first approval by the French National Agency for Medicines and Health Products Safety (ANSM) for Aptar Pharma’s Ophthalmic Dispenser.
Программа круглого стола "Актуальные вопросы офтальмологии. Приверженность к лечению больных с глаукомой", 20 сентября 2019 года
ABSTRACT SUMMARY In this observational case-controlled study, investigators used OCT angiography to evaluate microvascular perfusion in the optic nerve head region of glaucomatous eyes with or without disc hemorrhage (DH). The researchers also studied the relationship between parapapillary choroidal microvascular dropout (MVD) and retinal nerve fiber layer (RNFL) thickness. The study included 82 eyes with open-angle glaucoma (OAG) and DH and 68 OAG eyes without DH, all of which had at least four serial OCT angiography examinations. Outcome measures included MVD detection rate, extent of MVD, and RNFL thinning rate. MVD was defined as complete loss of microvasculature within the choroidal layer of the parapapillary region.
"Want to try something different which past attending surgeons and faculty have really enjoyed? I invite you to Orlando to experience a meeting like no other – exciting, useful, intense and fun – the way education is supposed to be!"
A federal jury has ordered Imprimis Pharmaceuticals to pay $48,500 in damages to Allergan, far less than Allergan was seeking, for lost business due to false advertising by the compounding company. In the lawsuit against Harrow Health Inc., formerly known as Imprimis Pharmaceuticals, Allergan requested damages of more than $7.2 million in lost profits and as much as $54 million in profit disgorgement, according to a Form 8-K filing to the U.S Securities and Exchange Commission by Harrow Health.
Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently undertreated. The consequences of undiagnosed and/or undertreated OSD can impact patient quality of life and severely affect visual acuity, especially in those undergoing cataract and/or refractive surgery. Effective diagnostics and therapeutics have been limited, but recent approvals by the US Food and Drug Administration as well as continued evaluation of new therapy modalities have the potential to enhance outcomes in patients with OSD. In this publication series, Ocular Surface Diseases, Disorders, & Dysfunctions® Volume 4, expert clinicians will review and evaluate pertinent advances in the diagnosis, management, and treatment of OSD, as well as offer clinical expertise for the management of challenging case presentations.
OCT Angiography imaging is a relatively new technology that generates large amounts of clinical information. It is therefore important to define a consistent method of assessing OCT Angiography images to streamline the interpretation and take full advantage of the data generated. This is a short instructional video which teaches a systematic approach to evaluating OCT Angiography images in 8 steps. The video features Christopher Mody, Director of Clinical Affairs, Heidelberg Engineering Limited and Dr. Richard Gale, Consultant Medical Ophthalmologist, York Teaching Hospital NHS Foundation Trust
Evidence from randomized controlled trials supports the use of two less invasive glaucoma treatment options, selective laser trabeculoplasty and a microstent. By Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed); and Keith Barton, MD, FRCP, FRCS
Что "заставляет" Вас заниматься научными исследованиями?
Популярная пресса
Интересное видео
Клуб молодых офтальмологов

МОО "Глаукомное общество"

Экспертный совет по глаукоме

Диабет. Рекомендации

Глаукома. Рекомендации ICO

Новостная лента на Twitter
Новости зарубежной офтальмологии